Nektar Therapeutics Statistics
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
39.94-0.325 (-0.81%)
Market open · Delayed 15 min · as of Oct 8, 9:54 AM ET
Nektar Therapeutics by the numbers
Nektar Therapeutics has a market capitalization of $1.36 billion based on 34.14M shares outstanding. With trailing EPS of $-18.96, Nektar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 41.0% below its 50-day average and 38.9% below its 200-day average.
Average daily trading volume is 1.06M shares, or about $42.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NKTR valuation vs. peer median
| Metric | NKTR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.36B | $1.37B | -0% |
| Avg. volume | 1.06M | 523.37K | +102% |
Peer median across 8 companies: AAPG, ANAB, TYRA, OMER, KLRA, KARD, GHRS, KRSA.
Valuation
- Market cap
- $1.36B
- EPS (TTM)
- $-18.96
- Shares outstanding
- 34.14M
Price and trading
- Previous close
- 40.26
- Open
- 39.89
- Day range
- 39.01 – 40.09
- 52-week range
- 33.40 – 109.00
- 52-week change
- -30.59%
- Beta
- —
- Volume
- 86.06K
- Average volume
- 1.06M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.36B
- Forward Pe
- -3.92
- Eps
- -18.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 109.00
- Week52 Low
- 33.40
- Avg Volume
- 1.06M
- Shares Outstanding
- 34.14M
- Ma50
- 67.67
- Ma200
- 65.33
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -63.36%
- Pct From52w Low
- 19.57%